SuperworthAtriCure profit margin ATRC
Gross, operating and net profit as a share of revenue over the last twelve months, from 2011.
- Net margin, 12 months
- 1.9%
- Operating margin, 12 months
- 2.3%
- Net margin on a year earlier
- +9.1 pts
- Peer median
- 10.3%
Over the twelve months to Jun 30, 2026, AtriCure kept 1.9% of its revenue as net profit, with an operating margin of 2.3% and a gross margin of 76.3%.
Five years earlier its net margin was −23.3%.
The median for 10 medical instruments and supplies stocks of a similar size is 10.3%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −2.1% | −1.8% | 75.0% |
| FY2024 | −9.6% | −8.6% | 74.7% |
| FY2023 | −7.6% | −6.7% | 75.2% |
| FY2022 | −14.1% | −12.9% | 74.4% |
| FY2021 | 18.3% | 20.1% | 75.0% |
| FY2020 | −23.3% | −21.4% | 72.3% |
| FY2019 | −15.2% | −14.4% | 73.8% |
| FY2018 | −10.5% | −8.5% | 73.0% |
| FY2017 | −15.4% | −14.3% | 72.2% |
| FY2016 | −21.5% | −20.1% | 71.6% |
| FY2015 | −21.0% | −20.6% | 71.6% |
| FY2014 | −15.1% | −15.2% | 70.5% |
| FY2013 | −14.0% | −13.3% | 72.7% |
| FY2012 | −10.7% | −10.2% | 71.2% |
| FY2011 | −8.5% | −7.3% | 73.0% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | 1.9% | +9.1 pts | 2.3% | |
| Q1 FY26 | −0.8% | +7.1 pts | −0.5% | |
| Q4 FY25 | −2.1% | +7.5 pts | −1.8% | |
| Q3 FY25 | −5.6% | +3.1 pts | −5.1% | |
| Q2 FY25 | −7.3% | +2.1 pts | −6.8% | |
| Q1 FY25 | −8.0% | +1.0 pts | −7.3% | |
| Q4 FY24 | −9.6% | −2.0 pts | −8.6% | |
| Q3 FY24 | −8.7% | −2.2 pts | −7.6% | |
| Q2 FY24 | −9.3% | −1.7 pts | −8.1% | |
| Q1 FY24 | −9.0% | +1.8 pts | −7.7% | |
| Q4 FY23 | −7.6% | +6.4 pts | −6.7% | |
| Q3 FY23 | −6.5% | +11.2 pts | −5.8% |
Against its peers
Companies in Medical - Instruments & Supplies nearest AtriCure's size, closest first, today.
| Company | Profit margin |
|---|---|
| ATRCAtriCure | 1.9% |
| WRBYWarby Parker | 0.8% |
| NVSTEnvista | 3.3% |
| UFPTUFP Technologies | 11.4% |
| ICUIICU Medical | 1.4% |
| INSPInspire Medical Systems | 15.0% |
| BMIBadger Meter | 14.3% |
| VNTVontier | 11.3% |
| LMATLemaitre Vascular | 25.0% |
| HAEHaemonetics | 7.1% |
| MMSIMerit Medical Systems | 9.2% |
| Peer median | 10.3% |
Where AtriCure ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on AtriCure
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.